Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-15
DOI
10.3389/fonc.2022.859152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulation of PD-L1 expression in the tumor microenvironment
- (2021) Ming Yi et al. Journal of Hematology & Oncology
- Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients
- (2021) Aliki Ntzifa et al. Scientific Reports
- Role of circulating tumor cells in diagnosis of lung cancer: a systematic review and meta-analysis
- (2021) Qingtao Zhao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution
- (2021) Lei Zhao et al. ONCOGENE
- Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients
- (2021) Liu Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation
- (2021) Ângela Carvalho et al. Cancers
- The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
- (2021) Cláudia Freitas et al. Frontiers in Oncology
- Combination of CT and telomerase-positive circulating tumor cells improves diagnosis of small pulmonary nodules
- (2021) Wen Zhang et al. JCI Insight
- Circulating tumor cells as a promising target for individualized drug susceptibility tests in cancer therapy
- (2021) Daniel J. Smit et al. BIOCHEMICAL PHARMACOLOGY
- Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer
- (2021) Léa Sinoquet et al. CLINICAL CHEMISTRY
- NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
- (2021) Estela Sánchez‐Herrero et al. Molecular Oncology
- Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis
- (2021) Lingling Wan et al. Frontiers in Oncology
- Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer
- (2021) Say Li Kong et al. Frontiers in Oncology
- Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study
- (2021) Pasquale Pisapia et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer
- (2021) Miao Huang et al. International Journal of General Medicine
- Circulating tumor cells are associated with recurrent disease in patients with early stage non-small cell lung cancer treated with stereotactic body radiation therapy
- (2020) Melissa A. Frick et al. CLINICAL CANCER RESEARCH
- Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer
- (2020) Guo-Chen Duan et al. OncoTargets and Therapy
- Molecular profiling for precision cancer therapies
- (2020) Eoghan R. Malone et al. Genome Medicine
- Continuous Microfluidic Purification of DNA Using Magnetophoresis
- (2020) Ying Xu et al. Micromachines
- High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients
- (2020) Mina Zeinali et al. Cancers
- Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
- (2020) Nicolas Guibert et al. European Respiratory Review
- Identification of circulating tumor cells using 4‐color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low‐dose computed tomography–detected lung nodules
- (2020) Ruth L. Katz et al. CANCER CYTOPATHOLOGY
- The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal
- (2020) Valerio Gristina et al. CANCER TREATMENT REVIEWS
- Understanding the role of phenotypic switching in cancer drug resistance
- (2020) Einar Bjarki Gunnarsson et al. JOURNAL OF THEORETICAL BIOLOGY
- Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells from Patients with Non-Small-Cell Lung Cancer
- (2020) Yuxin Cheng et al. Cancer Management and Research
- KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
- (2020) Mariantonia Nacchio et al. Journal of Thoracic Disease
- Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
- (2020) Charles-Hugo Marquette et al. Lancet Respiratory Medicine
- Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy
- (2020) Maria A Papadaki et al. Cancers
- The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells
- (2020) Arutha Kulasinghe et al. Cells
- Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
- (2020) Laura Keller et al. BRITISH JOURNAL OF CANCER
- Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer
- (2020) Hsin-Lun Lee et al. Cancers
- Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel
- (2019) Jian Zhou et al. Microsystems & Nanoengineering
- Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
- (2019) Arutha Kulasinghe et al. Cancers
- PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer
- (2019) Yang Wang et al. Scientific Reports
- Neutrophils escort circulating tumour cells to enable cell cycle progression
- (2019) Barbara Maria Szczerba et al. NATURE
- Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-positive Advanced Non-small-cell Lung Cancer in the Global Phase III ALEX Study
- (2019) D. Ross Camidge et al. Journal of Thoracic Oncology
- Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLC
- (2019) Ibiayi Dagogo-Jack et al. Journal of Thoracic Oncology
- Heterogeneous expression of programmed death receptor-ligand 1 on circulating tumor cells in patients with lung cancer
- (2019) Yasuhiro Koh et al. Clinical Lung Cancer
- Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
- (2019) Zujun Que et al. Cancer Cell International
- Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
- (2019) A T Shaw et al. ANNALS OF ONCOLOGY
- Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
- (2019) Tania Mamdouhi et al. CANCER AND METASTASIS REVIEWS
- Early Detection of Recurrence in Patients with Locally Advanced Non-small Cell Lung Cancer via Circulating Tumor Cell Analysis
- (2019) Chimbu Chinniah et al. Clinical Lung Cancer
- The Roles of MicroRNA in Lung Cancer
- (2019) Kuan-Li Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer
- (2019) Mengyuan Lyu et al. OncoTargets and Therapy
- Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients
- (2019) Silvina Ribeiro-Samy et al. Scientific Reports
- Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
- (2019) Yang Li et al. Cancer Medicine
- Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study
- (2019) Guannan Kang et al. BMC CANCER
- The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells
- (2019) Marianna Gallo et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
- (2019) Edward B. Garon et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
- (2019) Heather Scharpenseel et al. Scientific Reports
- Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival
- (2019) Ajay Balakrishnan et al. Scientific Reports
- Comprehensive analysis of EGFR T790M detection by ddPCR and ARMS-PCR and the effect of mutant abundance on the efficacy of osimertinib in NSCLC patients
- (2019) Yue Li et al. Journal of Thoracic Disease
- Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
- (2019) Menno Tamminga et al. Journal for ImmunoTherapy of Cancer
- Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
- (2019) Melanie Janning et al. Cancers
- PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
- (2019) Yariswamy Manjunath et al. Cancers
- Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC
- (2019) Kloten et al. Cells
- Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2019) Emma Pailler et al. CLINICAL CANCER RESEARCH
- The Androgen Receptor Splice Variant AR-V7 as a Biomarker of Resistance to Androgen-axis Targeted Therapies in Advanced Prostate Cancer
- (2019) Tian Zhang et al. Clinical Genitourinary Cancer
- EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
- (2019) C.R. Lindsay et al. EUROPEAN JOURNAL OF CANCER
- Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
- (2019) Stephanie N. Shishido et al. Journal of Translational Medicine
- Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
- (2019) Peter T Harrison et al. SEMINARS IN CANCER BIOLOGY
- Plasma next generation sequencing and droplet digital PCR‐based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent‐line osimertinib
- (2019) Pei N. Ding et al. Thoracic Cancer
- Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment
- (2019) Po‐Lan Su et al. Cancer Medicine
- LBA5_PROsimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis
- (2019) S S Ramalingam et al. ANNALS OF ONCOLOGY
- An Integrated Microfluidic Chip and Its Clinical Application for Circulating Tumor Cell Isolation and Single‐Cell Analysis
- (2019) Mingxin Xu et al. CYTOMETRY PART A
- Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics
- (2019) Edward Geeurickx et al. MOLECULAR ASPECTS OF MEDICINE
- Microfluidic Technologies for cfDNA Isolation and Analysis
- (2019) Xu et al. Micromachines
- Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?
- (2019) Elisabetta Rossi et al. Frontiers in Genetics
- Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I–III Non-small Cell Lung Cancer Patients
- (2019) Jingsi Dong et al. Frontiers in Oncology
- Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
- (2019) Eirini Papadopoulou et al. PLoS One
- Epithelial Mesenchymal Transition in Tumor Metastasis
- (2018) Vivek Mittal Annual Review of Pathology-Mechanisms of Disease
- Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans
- (2018) ANTICANCER RESEARCH
- Exosomes in lung cancer diagnosis and treatment. From the translating research into future clinical practice
- (2018) Christos Masaoutis et al. BIOCHIMIE
- Exosome-Based Detection ofEGFRT790M in Plasma from Non–Small Cell Lung Cancer Patients
- (2018) Elena Castellanos-Rizaldos et al. CLINICAL CANCER RESEARCH
- TRACERx: Tracking tumor evolution to impact the course of lung cancer
- (2018) Marcelo Vailati Negrao et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR -Mutated NSCLC
- (2018) Anna Buder et al. Journal of Thoracic Oncology
- A Phase II Study of Pembrolizumab in EGFR-mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC
- (2018) A. Lisberg et al. Journal of Thoracic Oncology
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice
- (2018) Annalisa Milano et al. Analytical Cellular Pathology
- Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer
- (2018) Manjima Dhar et al. Scientific Reports
- Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer
- (2018) Luojun Chen et al. Scientific Reports
- ALK- rearrangement in non-small-cell lung cancer (NSCLC)
- (2018) Xue Du et al. Thoracic Cancer
- Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
- (2018) Shrujal Baxi et al. BMJ-British Medical Journal
- Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis
- (2018) Shrujal Baxi et al. BMJ-British Medical Journal
- The role of liquid biopsy in predicting post-operative recurrence of non-small cell lung cancer
- (2018) Hengrui Liang et al. Journal of Thoracic Disease
- Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
- (2018) Galatea Kallergi et al. Therapeutic Advances in Medical Oncology
- ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress
- (2018) Martin H.D. Neumann et al. Computational and Structural Biotechnology Journal
- Highly sensitive and specific real-time PCR by employing serial invasive reaction as a sequence identifier for quantifying EGFR mutation abundance in cfDNA
- (2018) Zheng Xiang et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Analysis of single circulating tumor cells (CTCs) to identify resistance mutations to ALK-inhibitors in both ALK-gene and bypass oncogenic pathways.
- (2018) Emma Pailler et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
- (2018) Matteo Turetta et al. Cancers
- The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
- (2018) Joanna Kapeleris et al. Frontiers in Oncology
- Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics
- (2018) Alice Lallo et al. BRITISH JOURNAL OF PHARMACOLOGY
- A 5-MicroRNA Signature Identified from Serum MicroRNA Profiling Predicts Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer
- (2018) Yajie Zhang et al. CARCINOGENESIS
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report
- (2018) Karim Rihawi et al. Translational Oncology
- Survival Mechanisms and Influence Factors of Circulating Tumor Cells
- (2018) Wen-Chao Wang et al. Biomed Research International
- The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancer
- (2018) Arutha Kulasinghe et al. Cancer Medicine
- False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making
- (2017) Paul F Pinsky et al. JOURNAL OF MEDICAL SCREENING
- Recent Advances in Targeting ROS1 in Lung Cancer
- (2017) Jessica J. Lin et al. Journal of Thoracic Oncology
- Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis
- (2017) Chee Khoon Lee et al. Journal of Thoracic Oncology
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device
- (2017) Bee Luan Khoo et al. Nature Protocols
- Search for liquid biopsy grail points the way to drug discovery and development gems
- (2017) Chris Morrison NATURE REVIEWS DRUG DISCOVERY
- Enrichment and single-cell analysis of circulating tumor cells
- (2017) Yanling Song et al. Chemical Science
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- Microfluidics Based Point-of-Care Diagnostics
- (2017) Chandra M. Pandey et al. Biotechnology Journal
- PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?
- (2017) Cristina Raimondi et al. OncoImmunology
- Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
- (2016) M. Jamal-Hanjani et al. ANNALS OF ONCOLOGY
- Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC
- (2016) Phil A.J. Crosbie et al. Journal of Thoracic Oncology
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
- (2016) Glenwood Goss et al. LANCET ONCOLOGY
- Circulating tumor cell technologies
- (2016) Meghaan M. Ferreira et al. Molecular Oncology
- Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer
- (2016) Catherine W. Bennett et al. Oncotarget
- A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance
- (2016) Wenxian Wang et al. Cancer Medicine
- Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
- (2016) Lynnette Fernandez-Cuesta et al. EBioMedicine
- Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis
- (2015) Alfonso Fiorelli et al. ANNALS OF THORACIC SURGERY
- Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell Lung Cancer
- (2015) Guanshan Zhu et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Challenges in circulating tumor cell detection by the CellSearch system
- (2015) Kiki C. Andree et al. Molecular Oncology
- Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics
- (2015) Majid Ebrahimi Warkiani et al. Nature Protocols
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells
- (2014) Majid Ebrahimi Warkiani et al. ANALYST
- Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer
- (2014) Adrian G. Sacher et al. CANCER
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- “Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
- (2014) Marius Ilie et al. PLoS One
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
- (2014) Edward F. Patz et al. JAMA Internal Medicine
- Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
- (2014) Laura Muinelo-Romay et al. Cancers
- Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes
- (2013) D J E Peeters et al. BRITISH JOURNAL OF CANCER
- Circulating cell free DNA: Preanalytical considerations
- (2013) Safia El Messaoudi et al. CLINICA CHIMICA ACTA
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
- (2013) Neal I. Lindeman et al. Journal of Thoracic Oncology
- A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells
- (2013) Benjamin P. Casavant et al. METHODS
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
- (2013) E. Ozkumur et al. Science Translational Medicine
- Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
- (2012) E. A. Punnoose et al. CLINICAL CANCER RESEARCH
- Microfluidics and Circulating Tumor Cells
- (2012) Yi Dong et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
- (2012) Tateaki Naito et al. Journal of Thoracic Oncology
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
- (2012) D Ross Camidge et al. LANCET ONCOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
- (2011) A Lecharpentier et al. BRITISH JOURNAL OF CANCER
- A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
- (2011) F Farace et al. BRITISH JOURNAL OF CANCER
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
- (2010) V. Hofman et al. CLINICAL CANCER RESEARCH
- Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
- (2010) Véronique Hofman et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
- (2009) S. J. Cohen et al. ANNALS OF ONCOLOGY
- Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients
- (2009) Yoshitomo Okumura et al. ANNALS OF THORACIC SURGERY
- Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
- (2009) Jason P. Gleghorn et al. LAB ON A CHIP
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
- (2008) Steven J. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now